Literature DB >> 22171993

Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer.

Valentin Goede1, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, Udo Holtick, Janina Neuneier, Thomas C Koslowsky, Martin R Weihrauch, Michael von Bergwelt-Baildon, Ulrich T Hacker.   

Abstract

Tie2-expressing monocytes (TEM) promote tumor angiogenesis and growth in experimental cancer models. The role of TEM in cancer patients is unknown. We studied TEM in healthy volunteers and colorectal cancer (CRC) patients. Although TEM were detectable in the blood and tumor lesions of CRC patients, their frequency and functional phenotype showed no correlation with levels of angiopoietin-2 or vascular endothelial growth factor, microvessel density, tumor markers, tumor stage, or outcome of antiangiogenic therapy. These unexpected findings are at odds with murine tumor models and question the diagnostic or therapeutic value of TEM in human cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171993     DOI: 10.3109/07357907.2011.636114

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

1.  Circulating Tie2-Expressing Monocytes: A Potential Biomarker for Cervical Cancer.

Authors:  Qing Han; Quan Zhang; Feiquan Ying; Zehua Wang; Yifan Zhang; Lanqing Gong; E Cai; Jiaxian Qian; Jing Cai
Journal:  Onco Targets Ther       Date:  2020-09-07       Impact factor: 4.147

Review 2.  A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression.

Authors:  Victor Delprat; Carine Michiels
Journal:  Cancer Metastasis Rev       Date:  2021-03-30       Impact factor: 9.264

3.  Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer.

Authors:  Dominic Schauer; Patrick Starlinger; Christian Reiter; Nikolaus Jahn; Philipp Zajc; Elisabeth Buchberger; Thomas Bachleitner-Hofmann; Michael Bergmann; Anton Stift; Thomas Gruenberger; Christine Brostjan
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

4.  TIE-2 expressing monocytes in human cancers.

Authors:  Riccardo Turrini; Angélique Pabois; Ioannis Xenarios; George Coukos; Jean-François Delaloye; Marie-Agnès Doucey
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

Review 5.  Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.

Authors:  Louise A Elliott; Glen A Doherty; Kieran Sheahan; Elizabeth J Ryan
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

6.  Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages.

Authors:  Heidi Ehrentraut; Christina Weisheit; Marcel Scheck; Stilla Frede; Tobias Hilbert
Journal:  J Inflamm (Lond)       Date:  2018-06-14       Impact factor: 4.981

7.  Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.

Authors:  Yi-Feng He; Chao-Qun Wang; Yao Yu; Jing Qian; Kang Song; Qi-Man Sun; Jian Zhou
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

8.  Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis.

Authors:  Rita Campanelli; Gabriela Fois; Paolo Catarsi; Valentina Poletto; Laura Villani; Benedetta Gaia Erba; Luigi Maddaluno; Basilio Jemos; Silvia Salmoiraghi; Paola Guglielmelli; Vittorio Abbonante; Christian Andrea Di Buduo; Alessandra Balduini; Alessandra Iurlo; Giovanni Barosi; Vittorio Rosti; Margherita Massa
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

9.  Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma.

Authors:  Georgi Atanasov; Corinna Dietel; Linda Feldbrügge; Christian Benzing; Felix Krenzien; Andreas Brandl; Shadi Katou; Katrin Schierle; Simon C Robson; Katrin Splith; Georg Wiltberger; Anja Reutzel-Selke; Sven Jonas; Andreas Pascher; Marcus Bahra; Johann Pratschke; Moritz Schmelzle
Journal:  Oncotarget       Date:  2018-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.